期刊文献+

组织蛋白酶K升高是维持性血液透析患者心血管疾病死亡的危险因素 被引量:3

Elevated Cathepsin K is a Risk Factor for Cardiovascular Death in Maintenance Hemodialysis Patients
下载PDF
导出
摘要 目的探讨组织蛋白酶K水平与维持性血液透析(maintenance hemodialysis,MHD)患者心血管疾病(cardiovascular disease,CVD)死亡的关系。方法回顾性选择2017年1月~2019年12月连云港市第一人民医院血液净化中心96例MHD患者作为研究对象,另选择同期体检中心96例健康人群作为对照。采用电化学发光法检测血清组织蛋白酶K水平,采用Spearson相关分析血清组织蛋白酶K水平与临床病理特征及实验室指标的相关性,CVD死亡的危险因素采用Logistic回归分析。结果MHD组患者血清组织蛋白酶K水平为(280.75±36.84)ng/L,高于健康对照组的(112.95±20.14)ng/L(t=39.158,P<0.001)。MHD存活组患者血清组织蛋白酶K水平为(224.56±38.95)ng/L,低于MHD因CVD死亡组的(417.21±35.99)ng/L(t=23.273,P<0.001)。MHD患者血清组织蛋白酶K水平与糖尿病史、白细胞计数呈负相关(r=-0.324,P=0.011;r=-0.311,P=0.009),与甲状旁腺激素、碱性磷酸酶、C反应蛋白呈正相关(r=0.411,P=0.002;r=0.487,P<0.001;r=0.418,P=0.002)。多因素Logistic回归分析显示,低血红蛋白水平、高组织蛋白酶K水平是影响MHD患者CVD死亡的危险因素(OR=1.125,95%CI:1.014~1.944,P=0.041;OR=2.012,95%CI:1.411~6.254,P=0.003)。结论MHD患者以及CVD死亡患者血清组织蛋白酶K水平显著升高,组织蛋白酶K是MHD患者CVD死亡危险因素标志物。 Objective To investigate the relationship between Cathepsin K level and cardiovascular disease(CVD)death in maintenance hemodialysis(MHD)patients.Methods From Jan 2017 to Dec 2019,96 MHD patients in the blood purification center of Lianyungang first people's hospital were selected as the research objects(MHD group,n=96).Another 96 healthy people in the physical examination center were selected as the control group(healthy control group,n=96).The serum cathepsin K level was detected by electrochemiluminescence.The correlation between serum cathepsin K level and clinicopathological features and laboratory parameters was analyzed by Pearson correlation.The risk factors of CVD death were analyzed by logistic regression.Results The serum Cathepsin K level of MHD group was 280.75±36.84 ng/L,which was significantly higher than that in healthy control group(112.95±20.14 ng/L,t=39.158,P<0.001).The serum Cathepsin K level of MHD survival group was 224.56±38.95 ng/L,which was significantly lower than that in CVD death group(417.21±35.99ng/L,t=23.273,P<0.001).The serum Cathepsin K level was negatively correlated with diabetes and white blood cell count(r=-0.324,P=0.011;r=-0.311,P=0.009),and positively correlated with parathyroid hormone,alkaline phosphatase and C-reactive protein(r=0.411,P=0.002;r=0.487,P<0.001;r=0.418,P=0.002).Low hemoglobin level and high Cathepsin K level were independent risk factors of CVD death in MHD patients(OR=1.125,95%CI:1.014~1.944,P=0.041;OR=2.012,95%CI:1.411~6.254,P=0.003).Conclusion The serum Cathepsin K level is significantly increased in MHD patients and CVD death patients,and Cathepsin K is a potential biomarker of CVD death in MHD patients.
作者 许品品 朱丹 姚希 XU Pin-pin;ZHU Dan;YAO Xi(Laboratory of the first people's Hospital of Lianyungang City,Jiangsu Province,Lianyungang 222061,China)
出处 《中国血液净化》 CSCD 2021年第10期661-664,共4页 Chinese Journal of Blood Purification
关键词 维持性血液透析 组织蛋白酶K 心血管疾病 生物标志物 Maintenance hemodialysis Cathepsin K Cardiovascular disease Biomarkers
  • 相关文献

参考文献5

二级参考文献27

  • 1Libby,P.Mechanisms of acute coronary syndromes and their implications for therapy. The New England Journal of Medicine . 2013
  • 2Serruys Patrick W,Morice Marie-Claude,Kappetein A Pieter,Colombo Antonio,Holmes David R,Mack Michael J,St?hle Elisabeth,Feldman Ted E,van den Brand Marcel,Bass Eric J,Van Dyck Nic,Leadley Katrin,Dawkins Keith D,Mohr Friedrich W.Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. The New England Quarterly . 2009
  • 3Xian Wu Cheng,Zhe Huang,Masafumi Kuzuya,Kenji Okumura,Toyoaki Murohara.??Cysteine Protease Cathepsins in Atherosclerosis-Based Vascular Disease and Its Complications(J)Hypertension . 2011 (6)
  • 4Li Xiang,Liu Zexuan,Cheng Zeen,Cheng Xianwu.Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease. Chonnam medical journal . 2012
  • 5Lina Hu,Xian Wu Cheng,Haizhen Song,Aiko Inoue,Haiying Jiang,Xiang Li,Guo-Ping Shi,Eiji Kozawa,Kenji Okumura,Masafumi Kuzuya.??Cathepsin K Activity Controls Injury-Related Vascular Repair in Mice(J)Hypertension . 2014 (3)
  • 6Sukhova GK,Shi GP,Simon DI,et al.Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. Journal of Clinical Investigation, The . 1998
  • 7E Lutgens,S P.M. Lutgens,B C.G. Faber,S Heeneman,M M.J. Gijbels,M P.J. de Winther,P Frederik,I van der Made,A Daugherty,A M. Sijbers,A Fisher,C J. Long,P Saftig,D Black,M J.A.P. Daemen,K B.J.M. Cleutjens.??Disruption of the Cathepsin K Gene Reduces Atherosclerosis Progression and Induces Plaque Fibrosis but Accelerates Macrophage Foam Cell Formation(J)Circulation . 2006 (1)
  • 8Kae Nakamura,Takeshi Sasaki,Xian Wu Cheng,Akihisa Iguchi,Kohji Sato,Masafumi Kuzuya.??Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation(J)Atherosclerosis . 2009 (2)
  • 9吴建芳,金沂,李国元.组织蛋白酶K、S与动脉粥样硬化及其斑块不稳定性的关系[J].临床心血管病杂志,2008,24(11):867-869. 被引量:8
  • 10王全珍,陈焕芹,马文健.老年冠心病患者血清和肽素水平变化及其影响因素[J].中国老年学杂志,2012,32(8):1685-1687. 被引量:10

共引文献32

同被引文献46

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部